Idiopathic multicentric Castleman disease - TAFRO results in high levels of mTOR activator SVEP1, tissue factor, and endotheliopathy

Autor: Lossos, Chen, Brown, Jenna, Sheikhbahaei, Sara, Hubben, Anne, Liu, Sharon C., McCrae, Keith R., Chaturvedi, Shruti, Naik, Rakhi P., Francischetti, Ivo M.B.
Zdroj: In Blood Vessels, Thrombosis & Hemostasis June 2024 1(2)
Databáze: ScienceDirect